Developing better adjuvants for HIV vaccines
Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA)
['FUNDING_OTHER'] · SCRIPPS RESEARCH INSTITUTE, THE · NIH-11161215
This study is working on finding the best mixes of ingredients for an HIV vaccine to make it more effective, so that people can have better protection against the virus in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SCRIPPS RESEARCH INSTITUTE, THE (nih funded) |
| Locations | 1 site (LA JOLLA, UNITED STATES) |
| Trial ID | NIH-11161215 on ClinicalTrials.gov |
What this research studies
This research focuses on improving HIV vaccine development by identifying the best combinations of immunogens and adjuvants. The project will create standardized protocols and assays to systematically evaluate these combinations before they enter clinical trials. By screening various formulations, the research aims to enhance the effectiveness of future HIV vaccines, ultimately leading to better protection against the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection who may benefit from improved vaccine options.
Not a fit: Patients who are already living with HIV and are seeking treatment rather than prevention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV vaccines that provide better immunity against the virus.
How similar studies have performed: Previous research has shown promise in developing effective adjuvants for vaccines, suggesting that this approach could yield significant advancements in HIV vaccine efficacy.
Where this research is happening
LA JOLLA, UNITED STATES
- SCRIPPS RESEARCH INSTITUTE, THE — LA JOLLA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHATTERJEE, ARNAB KUMAR — SCRIPPS RESEARCH INSTITUTE, THE
- Study coordinator: CHATTERJEE, ARNAB KUMAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus